E.B. Lansdon

1.4k citations

21 papers · 1000 indexed · h-index 16

Co-authors: Xiaohong Liu Magdeleine Hung Nilima Kutty Katherine M. Brendza Andrew J. Fisher Irwin H. Segel Susmith Mukund Gabriel Birkuš
Topics: HIV/AIDS drug development and treatment (16 papers)HIV Research and Treatment (15 papers)Pneumocystis jirovecii pneumonia detection and treatment (7 papers)
Cited by: Virology Infectious Diseases Organic Chemistry
Journals: Journal of Biological Chemistry Journal of Molecular Biology Biochemistry
Partner nations: United States South Korea Czechia

In The Last Decade

E.B. Lansdon

20 papers receiving 985 citations

Peers

Countries citing papers authored by E.B. Lansdon

Since Specialization

Citations

This map shows the geographic impact of E.B. Lansdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.B. Lansdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.B. Lansdon more than expected).

Fields of papers citing papers by E.B. Lansdon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.B. Lansdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.B. Lansdon. The network helps show where E.B. Lansdon may publish in the future.

Co-authorship network of co-authors of E.B. Lansdon

This figure shows the co-authorship network connecting the top 25 collaborators of E.B. Lansdon. A scholar is included among the top collaborators of E.B. Lansdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.B. Lansdon. E.B. Lansdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural and mechanistic insights into herpesvirus helicase–primase and its therapeutic inhibitors 2025 ·Nature Microbiology ·Qing Yao,Alexandre Mercier,A. Nayak,Lindsey May,Pui Yan Ho,Ariel Lewis-Ballester,(unknown),(unknown),(unknown),Jayanti Mukherjee,Christopher M. Richards,Roberto Mateo,Aesop Cho,E.B. Lansdon,Xinchao Yu	0
2	Design and Synthesis of Novel HIV-1 NNRTIs with Bicyclic Cores and with Improved Physicochemical Properties 2023 ·Journal of Medicinal Chemistry ·(unknown),Ondřej Baszczyňski,Martin Kaiser,Martin Dračínský,George Stepan,Yu‐Jen Lee,Boris Brumshtein,Helen Yu,Petr Jansa,E.B. Lansdon,Zlatko Janeba	11
3	Elucidating molecular interactions of L-nucleotides with HIV-1 reverse transcriptase and mechanism of M184V-caused drug resistance 2019 ·Communications Biology ·Magdeleine Hung,(unknown),Leanna Lagpacan,Lijun Zhang,Zucai Suo,E.B. Lansdon	20
4	Novel (2,6-difluorophenyl)(2-(phenylamino)pyrimidin-4-yl)methanones with restricted conformation as potent non-nucleoside reverse transcriptase inhibitors against HIV-1 2016 ·European Journal of Medicinal Chemistry ·Petr Šimon,Ondřej Baszczyňski,David Šaman,George Stepan,Eric Hu,E.B. Lansdon,Petr Jansa,Zlatko Janeba	14
5	Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase 2014 ·Journal of Medicinal Chemistry ·Kevin Currie,Jeffrey E. Kropf,(unknown),Peter Blomgren,Jianjun Xu,Zhongdong Zhao,(unknown),J. Andrew Whitney,(unknown),E.B. Lansdon,Patrícia Maciejewski,Ann Marie Rossi,Hong Rong,Jennifer Macaluso,J A Barbosa,Julie A. Di Paolo,Scott A. Mitchell	131
6	Synthesis and biological evaluation of phosphonate analogues of nevirapine 2012 ·Bioorganic & Medicinal Chemistry Letters ·Jay P. Parrish,L. Tong,Michael Wang,Xiaowu Chen,E.B. Lansdon,Carina Cannizzaro,Xubin Zheng,Manoj C. Desai,Lianhong Xu	21
7	New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action 2012 ·Journal of Biological Chemistry ·Manuel Tsiang,G.S. Jones,Anita Niedziela‐Majka,Elaine Kan,E.B. Lansdon,Wayne Huang,Magdeleine Hung,Dharmaraj Samuel,Nikolai Novikov,Yili Xu,Michael L. Mitchell,Hongyan Guo,Kerim Babaoglu,Xiaohong Liu,Romas Geleziunas,Roman Sakowicz	129
8	The HIV-1 Reverse Transcriptase M184I Mutation Enhances the E138K-Associated Resistance to Rilpivirine and Decreases Viral Fitness 2011 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Rima Kulkarni,Kerim Babaoglu,E.B. Lansdon,L Rimsky,Veerle Van Eygen,Gastón Picchio,Evguenia S. Svarovskaia,Michael D. Miller,Kirsten White	69
9	Mechanism of Resistance to GS-9148 Conferred by the Q151L Mutation in HIV-1 Reverse Transcriptase 2011 ·Antimicrobial Agents and Chemotherapy ·(unknown),Kirsten White,James Chen,E.B. Lansdon,S. Swaminathan,Michael D. Miller,Matthias Götte	8
10	Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design 2010 ·Journal of Medicinal Chemistry ·E.B. Lansdon,Katherine M. Brendza,Magdeleine Hung,Ruth Wang,Susmith Mukund,Debi Jin,Gabriel Birkuš,Nilima Kutty,Xiaohong Liu	191
11	N1-Alkyl pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase 2010 ·Bioorganic & Medicinal Chemistry Letters ·Michael L. Mitchell,Jong Chan Son,Hongyan Guo,(unknown),Eun Jung Cho,Jianhong Wang,(unknown),Michael Wang,Amber M. Paul,E.B. Lansdon,James Chen,(unknown),Gerry Rhodes,Gong-Xin He,Romas Geleziunas,Lianhong Xu,Choung U. Kim	12
12	Visualizing the Molecular Interactions of a Nucleotide Analog, GS-9148, with HIV-1 Reverse Transcriptase–DNA Complex 2010 ·Journal of Molecular Biology ·E.B. Lansdon,Dharmaraj Samuel,Leanna Lagpacan,Katherine M. Brendza,Kirsten White,Magdeleine Hung,Xiaohong Liu,Constantine G. Boojamra,Richard L. Mackman,Tomáš Cihlář,Adrian S. Ray,Mary E. McGrath,S. Swaminathan	37
13	N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase 2010 ·Bioorganic & Medicinal Chemistry Letters ·Michael L. Mitchell,Jong Chan Son,Ill Young Lee,Chong-Kyo Lee,Hae Soo Kim,Hongyan Guo,Jianhong Wang,(unknown),Michael Wang,Amber M. Paul,E.B. Lansdon,James Chen,(unknown),Romas Geleziunas,Lianhong Xu,Choung U. Kim	19
14	Affinities between the Binding Partners of the HIV-1 Integrase Dimer-Lens Epithelium-derived Growth Factor (IN Dimer-LEDGF) Complex 2009 ·Journal of Biological Chemistry ·Manuel Tsiang,G.S. Jones,Magdeleine Hung,Susmith Mukund,Bin Han,Xiaohong Liu,Kerim Babaoglu,E.B. Lansdon,Xiao‐Wu Chen,(unknown),(unknown),Nikos Pagratis,Roman Sakowicz,Romas Geleziunas	40
15	Mutations in the thumb–connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patients 2009 ·Antiviral Therapy ·(unknown),Wesley T. O’Neal,Kirsten White,Charles Wakeford,E.B. Lansdon,Jeanette Harris,Evguenia S. Svarovskaia,Michael D. Miller,Katyna Borroto–Esoda	19
16	RNase H Active Site Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Design, Biochemical Activity, and Structural Information 2009 ·Journal of Medicinal Chemistry ·Thorsten Kirschberg,M. Balakrishnan,Neil Squires,Tiffany Barnes,Katherine M. Brendza,Xiaowu Chen,Eugene Eisenberg,Weili Jin,Nilima Kutty,Stephanie A. Leavitt,Albert Liclican,Qi Liu,Xiaohong Liu,(unknown),Jason K. Perry,Michael Wang,William J. Watkins,E.B. Lansdon	86
17	Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase—Structure–activity relationships and crystallographic analysis 2007 ·Bioorganic & Medicinal Chemistry Letters ·Thorsten Kirschberg,M. Balakrishnan,Wei Huang,(unknown),Nilima Kutty,Albert Liclican,Damian J. McColl,Neil Squires,E.B. Lansdon	36
18	Crystal Structure of the Bifunctional ATP Sulfurylase – APS kinase from the Chemolithotrophic Thermophile Aquifex aeolicus 2006 ·Journal of Molecular Biology ·Zhihao Yu,E.B. Lansdon,Irwin H. Segel,Andrew J. Fisher	29
19	Human 3‘-Phosphoadenosine 5‘-Phosphosulfate Synthetase (Isoform 1, Brain): Kinetic Properties of the Adenosine Triphosphate Sulfurylase and Adenosine 5‘-Phosphosulfate Kinase Domains 2004 ·Biochemistry ·E.B. Lansdon,Andrew J. Fisher,Irwin H. Segel	29
20	Ligand-Induced Structural Changes in Adenosine 5‘-Phosphosulfate Kinase from Penicillium chrysogenum^, 2002 ·Biochemistry ·E.B. Lansdon,Irwin H. Segel,Andrew J. Fisher	29

About E.B. Lansdon

E.B. Lansdon is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 21 papers that have together received 1000 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). The work is most often cited by research in Virology (552 citations), Infectious Diseases (649 citations) and Organic Chemistry (189 citations). E.B. Lansdon has collaborated with scholars based in United States, South Korea and Czechia. Frequent co-authors include Xiaohong Liu, Magdeleine Hung, Nilima Kutty, Katherine M. Brendza, Andrew J. Fisher, Irwin H. Segel, Susmith Mukund, Gabriel Birkuš, Ruth Wang and Debi Jin. Their work appears in journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact